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Background
Rapid spread of coronavirus disease 2019 (COVID-19) has
affected people with intellectual disability disproportionately.
Existing data does not provide enough information to understand
factors associated with increased deaths in those with intellec-
tual disability. Establishing who is at high risk is important in
developing prevention strategies, given risk factors or
comorbidities in people with intellectual disability may be dif-
ferent to those in the general population.
Aims
To identify comorbidities, demographic and clinical factors of
those individuals with intellectual disability who have died from
COVID-19.
Method
An observational descriptive case series looking at deaths
because of COVID-19 in people with intellectual disability was
conducted. Along with established risk factors observed in the
general population, possible specific risk factors and comorbid-
ities in people with intellectual disability for deaths related to
COVID-19 were examined. Comparisons between mild and
moderate-to-profound intellectual disability subcohorts were
undertaken.
Results
Data on 66 deaths in individuals with intellectual disability were
analysed. This group was younger (mean age 64 years)
compared with the age of death in the general population
because of COVID-19. High rates of moderate-to-profound
intellectual disability (n = 43), epilepsy (n = 29), mental illness (n =
29), dysphagia (n = 23), Down syndrome (n = 20) and dementia
(n = 15) were observed.
Conclusions
This is the first study exploring associations between possible
risk factors and comorbidities found in COVID-19 deaths in
people with intellectual disability. Our data provides insight into
possible factors for deaths in people with intellectual disability.
Some of the factors varied between the mild and moderate-to-
profound intellectual disability groups. This highlights an urgent
need for further systemic inquiry and study of the possible
cumulative impact of these factors and comorbidities given the
possibility of COVID-19 resurgence.
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Background
Studies have highlighted how coronavirus disease 2019 (COVID-19)
continues to affect certain populations differently.1 Physical morbid-
ities such as obesity, hypertension, cardiovascular disease and dia-
betes have been identified as high-risk factors and comorbidities,
along with belonging to ethnic minorities in high- income countries,
and also old age.2,3 This has led to developing risk stratification
methods, so that preventative strategies such as shielding can be
focused on individuals who belong to high-risk categories (https://
www.coh-fit.com/about-the-project/).3
Over 500 people with an intellectual disability (also known as
learning disability in UK health services) had died from COVID-19
in England by July 2020 (https://www.england.nhs.uk/publication/
covid-19-deaths-of-patients-with-a-learning-disability-notified-to-
leder/).4 Certain risk factors and comorbidities that are common in
people with intellectual disability such as epilepsy and dysphagia
are postulated to be possible reasons.5 People with intellectual disabil-
ity are more likely to have severe physical illnesses and/or disabil-
ities.5 A person with an intellectual disability may have numerous
long-term conditions.6
Among people with intellectual disability, there is considerable
over-representation of certain conditions such as epilepsy (22.5%)
relative to the general population (0.6%).7,8 Epilepsy contributes
to significantly higher premature mortality9,10 in people with
intellectual disability. Pneumonia or aspiration pneumonia (to
which dysphagia is a precursor) is considered a major risk factor
for premature mortality for people with intellectual disability.11
Dysphagia was associated with 38% of all identified premature mor-
tality in people with ID and combined with epilepsy was found in
18% of all premature ID deaths.9
Although it is recognised that genetic anomalies play a signifi-
cant role in premature mortality in people with intellectual disabil-
ity, they have been poorly researched. Common conditions such as
Down syndrome are recognised to be overrepresented in the mor-
tality figures. It is estimated that 13% of the premature mortality
sample of Learning Disabilities Mortality Review (LeDeR) had
Down syndrome.9 People with Down syndrome are highly vulner-
able to dementia. Dementia is an associated factor for premature
mortality with both epilepsy (11%) and dysphagia (13%).9
Mental health problems and intellectual disability
Higher levels of mental health problems occur in people with intel-
lectual disability.12 They independently contribute to 10–25 years
earlier mortality. From LeDeR investigations it is known that 23%
of all reported deaths were in individuals who had a mental
illness diagnosis.8 In addition, there is recognition of the undue
negative impact of psychotropic medication, such as antipsychotics,
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that negatively impact on premature mortality in people with intel-
lectual disability.8
People with intellectual disability are more likely to require
support from others including their families or paid carers in the
community or in residential homes.13,14 Such models of care
increase the social risk of transmission of infection from carers
who often do shift work, possibly at multiple sites, as has occurred
in care homes for people with dementia.1
There are no published reports looking at risk factors or
comorbidities in people with intellectual disability. The risk of a
resurgence of COVID-19 is high as only 6.5% of the population
in the UK was reported to have antibodies to the virus in July
2020, far from reaching herd immunity.15 Consequently, physicians
and psychiatrists caring for people with intellectual disability face
the dilemma of identifying who is at higher risk from an already
highly vulnerable population in order to take necessary measures
to protect them from the infection and reduce mortality. Blanket
isolation measures for a person with an intellectual disability can
have an impact on their mental health given their routines and
daily activities tend to be well structured and predictable. There is
the added risk of inadvertent deprivation of liberty because of
disproportionate social restrictive measures.16
Aims
There is an urgent need to understand if general population risk
factors and comorbidities apply synchronously to the intellectual
disability population, and if there are added risk issues from




This is an observational descriptive study of people with intellectual
disability who have died from COVID-19 to generate hypotheses on
specific risk factors and comorbidities that may increase the risk of
death from COVID-19 in this population.
Consultant psychiatrists and intellectual disability service leads
in England and Ireland were contacted through various networks
and asked to fill in a data sheet of possible risk factors and
comorbidities in individuals with intellectual disability who had
died because of COVID-19 from 1 March 2020 (chosen as a few
days prior to the first death from COVID-19 reported in
England) and 19 June 2020. A 2-week period from 8 June to 19
June was provided for data collection.
The numbers of deaths in people with intellectual disability was
low. Therefore, data in this study was gained through an exponential
non-discriminative snow-balling methodology17 in which psychia-
trists and clinicians working in intellectual disability services col-
lected data and provided further contacts who could provide
more data on deaths in intellectual disability until the data collection
deadline.
Demographic risk factors that are present in the general popu-
lation and therefore may also be risk factors in people with intellec-
tual disability were investigated. These included age, gender and
ethnicity. We then identified health risk factors or comorbidities
that have been shown to be risk factors in the general population
for death from COVID-19.2,3 These included dementia, diabetes,
hypertension, obesity, smoking status and asthma. Finally, a panel
of experts in managing physical and mental health conditions in
people with intellectual disability (consultant psychiatrists, a
general practitioner, a pharmacist, academics in research method-
ology and statistics) hypothesised possible specific risk factors and
comorbidities for people with intellectual disability based on avail-
able evidence. These were severity of intellectual disability, need for
multiple carers, epilepsy, presence of dysphagia, genetic syndromes
specifically Down syndrome, autism, attention-deficit hyperactivity
disorder (ADHD), mental illness, challenging behaviour and pre-
scriptions for antipsychotics.
The prevalence of individual risk factors or comorbidities, and
their combination was examined in those who died. The severity
of intellectual disability was divided intomild andmoderate-to-pro-
found intellectual disability.
Rationale of dividing the group in to mild andmoderate-
to-profound intellectual disability
(a) Each of the three subgroups of ICD-1018 moderate (F71),
severe (F72) and profound intellectual disability (F73) have a
low prevalence (9% moderate intellectual disability, 4%
severe intellectual disability, and about 2% profound) and
together they would comprise 15% of the total intellectual dis-
ability population.19 Taken individually it would be difficult to
achieve satisfactory power to deliver meaningful conclusions.
(b) Moderate, severe and profound intellectual disability is difficult
to assess and classify, which causes significant issues with the
accuracy of specific diagnosis of degree of intellectual disability.
Ethics
Each site investigator submitted the project protocol and sample
excel datasheet to their local health/social care organisations’ infor-
mation and governance leads to obtain written permission to access
health records of those who had died due to COVID-19 while their
case was still open to the organisation. Each site confirmed that
ethical clearance is not necessary. Data on deaths were anonymised
at the site level before submitting data to the data coordinator for
analysis. Posthumous investigations with anonymous data are
exempted from undergoing formal ethical assessment.
Differences in the prevalence of risk factors or comorbidities,
between the mild and moderate-to-profound intellectual disability
subgroups was tested using Fisher’s exact test with significance
accepted at P≤ 0.05. STrengthening the Reporting of OBservational
studies in Epidemiology (The STROBE Checklist) was used to
guide and report this observational study (see Supplementary data
1 available at https://doi.org/10.1192/bjo.2020.102).
Results
During the 2 weeks of data collection, we received data on 82
COVID-19-related deaths in intellectual disability from learning
disability services in England and Ireland. In total 20 clinicians
from 18 sites contributed. Of these, two sites were excluded from
data analysis as not enough information on risk factors or
comorbidities were provided during the 2-week data collection
window period. Therefore 66 deaths in England (n = 63) and
Ireland (n = 3) were analysed in this paper.
Main findings are listed in Table 1. Data showed an age range of
31 to 88 with a median age of 64. Figure 1 shows the age distribution
of all COVID-19 deaths. Of the deaths 39 were in men and 27 in
women. Five patients were Black and minority ethnic.
In total, 54 of the 66 deceased never smoked. Data on body mass
index (BMI) were missing for nearly a third of people. Of the
remaining available data, 21 of the deaths were recorded in indivi-
duals within the normal BMI range and another 21 were categorised
as either overweight or obese.
Regarding physical health conditions, the most common was a
diagnosis of epilepsy (n = 29) followed by dysphagia (n = 23),
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dementia (n = 15), hypertension (n = 11), asthma (n = 11) and dia-
betes (n = 9).
Considering mental health parameters, 11 had a diagnosis of
severe mental illness. In total, 18 were listed as having any other
mental illnesses, with a total of 29 of the sample having some type
of mental illness. Just over a third (n = 23) had presented with chal-
lenging behaviour. There were 19 who were on antipsychotic
medications.
Approximately a third (n = 20) of the sample had Down syn-
drome. Six of the deaths of people with Down syndrome were in
people with mild intellectual disability and 14 were in people with
moderate-to-profound intellectual disability. The age range for
deaths in Down syndrome was 44–67 and the median age was 58.
The number of deaths in people diagnosed with autism (n = 6)
and ADHD (n = 1) were very low.
Discussion
To our knowledge, this is the only case series examining probable
risk factors and comorbidities in people with intellectual disability
for COVID-19, with data collected systematically on deaths in
people with intellectual disability because of COVID-19 in
England and Ireland. The analysis of different demographic and
physical and mental health data gives an insight into the possible
factors associated with COVID-19 deaths in people with intellectual
disability. Reports on increased mortality and a predicted second
wave of COVID-19 highlight the importance of exploring specific
factors and comorbidities that may put people with intellectual dis-
ability at greater risk without delay.
This discussion will focus on demographic and physical and
mental health data identified in this study compared with the exist-
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Fig. 1 Age distribution of all COVID-19 deaths in people with
intellectual disabilities.
Table 1 Prevalence of risk factors and comorbidities for COVID-19
deaths in people with intellectual disability (n = 66)
Factor n %
Age, years
18 to <50 7 11
50 to <60 17 26
60 to <70 24 37





Body mass index (BMI)
Normal BMI 21 50
Overweight (25–30 BMI) 11 26











Severity of intellectual disability
Mild 22 34






Family home 11 17
Supported living 26 39
Residential care 21 32
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Demographic data
Data for age-specific mortality from COVID-19 in the general
population has shown that the age group of 90 years and over has
the highest risk of death from COVID-19. Our case series shows
that the median age group is 64, which is younger compared with
a non-intellectual disability group.3 However, this needs to be
read with caution given that average age expectation is lower in
people with intellectual disability compared with a non-intellectual
disability population.
Physical and mental health considerations
It is well established that people with intellectual disability have
more health problems compared with people without intellectual
disability.5 Furthermore, the prevalence of certain physical health
conditions is higher in people with moderate-to-profound intellec-
tual disability compared with people with mild intellectual disabil-
ity. Of particular interest is the subanalysis of the prevalence of
epilepsy within the intellectual disability group with an increased
prevalence of epilepsy occurring in mild intellectual disability
(9/22 v. 20/43 in the moderate-to-profound intellectual disability
group) but with no statistical difference between the two groups.
People with mild intellectual disability have a 8–10% seizure
comorbidity compared with 30–50% in the moderate-to-profound
group.7,8 This generates a hypothesis that epilepsy may be an asso-
ciated factor for death from COVID-19 in this population and par-
ticularly in the mild intellectual disability group.
A prevalence rate of 9.8% for hypertension is reported for
people with intellectual disability;20 however, presence of
hypertension in 11 out of 59 COVID-19 intellectual disability
deaths suggests a higher prevalence in this smaller database. Of
particular interest is that hypertension was a more significantly
associated factor in people with mild intellectual disability than
in those with moderate-to-profound intellectual disability
(Table 2).
There is no pre-COVID-19-specific mortality data for people
with intellectual disability for hypertension, diabetes or asthma,
which limits the ability to understand the importance of these
health parameters found in the current data sample. Dysphagia
has been recognised to be significantly associated with aspiration
pneumonia and increased mortality in people with intellectual dis-
ability. Both dysphagia and associated mortality are significantly
higher in people with moderate-to-profound intellectual disabil-
ity.21 In our case series 19 out of 43 deaths in individuals with
moderate-to-profound intellectual disability had a diagnosis of dys-
phagia compared with 4 out of 22 in the mild intellectual disability
group.
Approximately a third (n = 20) of individuals who died had a
diagnosis of Down syndrome. Prevalence of Down syndrome in
intellectual disability is around 2.5%.22 The finding that 20 of
the people with intellectual disability who died had Down syn-
drome is a cause for concern. This is also higher compared with
LeDeR data,9 which reports approximately 16% of deaths in
their cohort had Down syndrome. However, the median age of
death of 58 found in this sample is similar to findings in the
LeDer data. It can be assumed that the increased prevalence of
respiratory conditions and other health conditions found in
people with Down syndrome can predispose them to COVID-19
complications.
There is growing evidence that people with dementia are highly
vulnerable to COVID-19.3 Dementia was over-represented in the
deaths in this case series (15/48). We also considered ADHD and
autism, the two most prevalent comorbid neurodevelopmental dis-
orders among people with intellectual disability. They did not
emerge as likely higher risk factors among people who died from
COVID-19.
The high prevalence of mental illness in our sample compared
with pre-COVID-19 intellectual disability premature mortality is
an issue of concern. The presence of challenging behaviour as a
risk factor in 23/66 of those who died, compared with a prevalence
of 5–15% in the intellectual disability population23 needs to be
noted. This could be because of sample bias as most data were col-
lected by psychiatrists. No equivalent comparators are available
from the general population or pre-COVID-19 intellectual disability
deaths.
The use of antipsychotics in nearly a third of our sample com-
pared with in 19% pre-COVID-19 intellectual disability deaths sug-
gests the combined issue of mental health, challenging behaviour
and antipsychotic use requires further closer scrutiny, especially
when confounded by epilepsy and possibly its treatment.
However, it is again worth noting that data were collected by psy-
chiatrists who have access to data for people with intellectual dis-
ability and mental health issues.
Of all those who died, 55 out of 66 lived in supported living, resi-
dential or nursing homes. This leads to a hypothesis as to whether
exposure to multiple carers is associated with a high risk of dying
from COVID-19. This may not be unexpected given the rates of
deaths in care homes caring for people with dementia because of
COVID-19 in the UK. Establishing this as a risk factor along with
other risk factors would help to identify who is at high risk of
dying from COVID-19, and help to establish specific measures
that could be implemented to protect those at high risk who are
cared for by multiple carers rather than a blanket restriction on
everyone living in a care setting.
Table 2 Comparison of risk characteristics between individuals with





profound ID (n = 44) P-value
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Limitations and strengths
As a case series collated through a snow-balling methodology we do
not claim it is a systemically representative sample. It is not possible
to determine the actual population pattern of distribution. The use
of a peer network can lead to oversampling bias. Psychiatrists were
reached through different networks, so it is difficult to know the
number of people reached. The use of psychiatrists as the data col-
lection mediummay have caused high prevalence figures for mental
illness and antipsychotic usage. Further, it is not possible to deter-
mine the sampling error and make statistical inferences from the
sample to the ID population because of the absence of a random
selection of samples. In particular there is a risk of type 2 error
when comparing the conditions between the mild and moderate-
to-profound groups. Therefore it can only generate hypotheses
that need further testing through more systematic research
methodology.
Implications for research
This case series has generated the hypotheses that people with intel-
lectual disability may be more likely to die from COVID-19 infec-
tion if there is the presence of a single or a combination of factors
or comorbidities, These include moderate-to-profound intellectual
disability, epilepsy, living setting, dysphagia, dementia, mental
illness and Down syndrome. There also appears to be certain pos-
sible associated-factor differences between people with mild intel-
lectual disability compared with those with moderate-to-profound
intellectual disability. These hypotheses need to be tested by more
rigorous methodologies. Some factors may confound others and
should be examined further.
Future studies assessing risk factors and comorbidities would
need to consider a system that can collect data on deaths in intellec-
tual disability because of COVID-19 in a systematic way and for
comparison with a larger group of people with intellectual disability
(of similar nature and degree) without COVID-19 complications. It
also needs to be explored if people with intellectual disability in sup-
ported environments are more prone to infection and death, and if
so, what features of a care establishment that increase risks.
Implications for clinical and social practice
Future studies should focus on developing risk scores. Risk scores
will help to provide an understanding of the cumulative burden of
certain key conditions and more specific public health messages
for people with intellectual disability. Guidance is needed on the
stratification of risk for people with intellectual disability so that
the appropriate level of shielding can be given to individuals. This
may be the start of that process. Even though our data suggests
that people with intellectual disability with Down syndrome,
dementia, epilepsy, moderate-to-profound intellectual disability,
mental illness and dysphagia may be vulnerable to death from
COVID-19 infection, it is too early to draw conclusions. The
finding that 75% of those who died had at least two risk factors or
comorbidities could be used to actively identify those at great risk
in an already vulnerable population.
Implications for policy
The protection of individuals with intellectual disability in sup-
ported environments needs to be prioritised in any outbreak of
COVID-19. There are clearly lessons to be learned from care
homes for elderly people that are likely to also apply to care facilities
for people with intellectual disability, and policies will need to be
developed to protect people with intellectual disability. The moral
welfare of any society can be judged by the care of those most
vulnerable.
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